The Indian Journal of Chest Diseases and Allied Sciences

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  66 (2024)
Volume  65 (2023)
Volume  64 (2022)
Volume  63 (2021)
Volume  62 (2020)
Volume  61 (2019)
Volume  60 (2018)
Volume  59 (2017)
Volume  58 (2016)
Volume  57 (2015)
Volume  56 (2014)
Volume  55 (2013)
Volume  54 (2012)
Volume  53 (2011)
Volume  52 (2010)
Related articles

VOLUME 63 , ISSUE 2 ( April-June, 2021 ) > List of Articles

Original Article

Physical, Psycho-social and Economic Burden of Chronic Obstructive Pulmonary Disease: A Hospital-Based Study in Kolkata, West Bengal, India

R. Chakraborti, D.K. Mukhopadhyay, S. Mukherjee

Keywords : Psycho-social, Economic burden, COPD

Citation Information : Chakraborti R, Mukhopadhyay D, Mukherjee S. Physical, Psycho-social and Economic Burden of Chronic Obstructive Pulmonary Disease: A Hospital-Based Study in Kolkata, West Bengal, India. Indian J Chest Dis Allied Sci 2021; 63 (2):81-88.

DOI: 10.5005/ijcdas-63-2-81

License: CC BY-NC 4.0

Published Online: 18-11-2022

Copyright Statement:  Copyright © 2021; The Author(s).


Abstract

Objective: Chronic obstructive pulmonary disease (COPD) is a common chronic lung disease posing a huge challenge to the public health system of India. The present study was designed to assess the physical, psycho-social and economic burden of COPD depending on severity of airflow limitation. Methods: A cross-sectional, hospital-based study was done among 200 patients diagnosed with COPD attending a tertiary care hospital in Kolkata, West Bengal. COPD Assessment Test (CAT) questionnaire and modified British Medical Research Council Questionnaire were used to assess the physical burden of COPD on daily life and severity of the breathlessness. Psycho-social and economic burden were assessed with a structured, validated questionnaire. Results: Nearly half (46%) had severe or very severe airflow limitation as per predicted forced expiratory volume in the first second (FEV1). Severity of dyspnoea and CAT score increased linearly with the severity of the airflow limitation. In last 30 days, proportion of patients needing support in self-care and chores were 28% and 51%, respectively. Median (± interquartile range [IQR]) direct and indirect cost of managing COPD were Indian rupee (INR) 319.5 (± 55.0) and 49.5 (± 600.0), respectively. A considerable proportion (87%) of patients took recourse to different cost-cutting measures. Physical, psycho-social and economic burden had significant association with severity of airflow limitation. Conclusion: In our study, COPD had a staggering physical, psycho-social and economic burden on patients and their families.

PDF Share
  1. Global Initiative for Chronic Obstructive Lung Disease(GOLD). Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease (2019 report). Available from URL: https://goldcopd.org/wp-content/uploads/2018/11/GOLD-2019-v1.7-FINAL-14Nov2018-WMS.pdf. Accessed on July 17, 2019.
  2. Adeloye D, Chua S, Lee C, Basquill C, Papana A, Theodoratau E, et al. Global and regional estimates of COPD prevalence: systemic review and meta-analysis. J Global Health 2015;5:020415.
  3. Lazano R, Naqhavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012 15;380(9859):2095–2128.
  4. Jindal SK. Emergence of chronic obstructive pulmonary diseases as an epidemic in India. Indian J Med Res 2006;124:619–30.
  5. Bhome AB. COPD in India: iceberg or volcano? J Thorac Dis 2012;4:298–309.
  6. Miravitlles M, Ribera A. Understanding the impact of symptoms on the burden of COPD. Respir Res 2017;18:67.
  7. Izquierdo JL, Barcina C, Jimenez J, Munoz M, Leal M. Study of the burden on patients with chronic obstructive pulmonary disease. Int J Clin Pract 2009;63:87–97.
  8. Kessler R, Partridge MR, Miravitlles M, Cazzola M, Vogelmeier C, Leynaud D, et al. Symptom variability in patients with severe COPD: a pan-European crosssectional study. Eur Respir J 2011;37:264–72.
  9. Chest: American College of Chest Physicians [homepage on the Internet].CDC reports annual financial cost of COPD to be $36 billion in the United States [Posted 2014, July 24]. Available from URL: http://www.chestnet.org/News/Press-Releases/2014/07/CDC- reports-36-billionin- annual-financial-cost-of-COPD-in-US, Accessed on January 01, 2018.
  10. Shah M, Godbole V, Patel TK, Patel TR. Study of economic burden and health care resource utilization by chronic obstructive pulmonary disease patients in a tertiary care hospital in Western India. Natl J Commu Med 2017;8:535–40.
  11. Arkhipov V, Arkhipova D, Miravitlles M, Lazarev A, Stukalina E. Characteristics of COPD patients according to GOLD classification and clinical phenotypes in the Russian Federation: the SUPPORT trial. Int J Chron Obstruct Pulmon Dis 2017;12:3255–62.
  12. Shavro SA, Ezhilarasu P, Augustine J, Bechtel JJ, Devasahayam JC. Correlation of health related quality of life with other disease severity indices in Indian chronic obstructive pulmonary disease patients. Int J COPD 2012;7:291–6.
  13. Sinha B, Vibha, Singla R, Chowdhury R. An epidemiological profile of chronic obstructive pulmonary disease: a community based study in Delhi. J Postgrad Med 2017;63:29–35.
  14. Lipinska IK, Kuna P. Impact of chronic obstructive pulmonary disease (COPD) on patient's life and his family life. Pulmonol Alergol Pol 2014;82:82–95.
  15. Müllerová H, Lu C, Li H, Tabberer M. Prevalence and burden of breathlessness in patients with chronic obstructive pulmonary disease managed in primary care. PLoS One 2014;9:e85540.
  16. Kim S, Oh J, Kim Y, Ban HJ, Kwon YS, Oh IJ, et al. Difference in classification of COPD group using COPD assessment test (CAT) or modified Medical Research Council (mMRC) dyspnoea scores: a cross-sectional analyses. BMC Pulmon Med 2013;13:35.
  17. Ghobadi H, Ahari SS, Kameli A, Lari SM. The relationship between COPD Assessment Test (CAT) scores and severity of aitflow obstruction in stable COPD patients. Tanaffos 2012;11:22–26.
  18. Brien SB, Lewith GT, Thomas M. Patient coping strategies in COPD across disease severity and quality of life: a qualitative study. NPJ Prim Care Respir Med 2016;26:16051.
  19. Alvarez-Gutierrez FJ, Miravitlles M, Calle M, Gobratt E, Lopez F, Martin A, et al. Impact of chronic obstructive pulmonary disease on activities of daily living: results from the EIME multicenter study. Arch Bronconeumol 2007;43:64–72.
  20. Elkington H, White P, Addington-Hall J, Higgs R, Pettinari C. The last year of life with COPD: a qualitative study of symptoms and services. Respir Med 2004;98:439–45.
  21. Biswas D, Mukherjee S, Chakroborty R, Chatterjee S, Rath S, Das R, et al. Occurrence of anxiety and depression among stable COPD patients and its impact on functional capability. J Clin Diag Res 2017;11:OC24-OC27. DOI: 10.7860/JCDR/2017/24203.9393.
  22. News: Medical, Life Sciences: Home page: Social and economic impact of COPD on working population. Available from URL: https://www.news-medical.net/news/20110926/Social-and-economic-impact-of- COPD-on-workingpopulation. aspx. Accessed on September 27, 2017.
  23. Murthy KJR, Sastry JG. Economic burden of chronic obstructive pulmonary disease. NCMH background papers – burden of disease in India. Available from URL: http://www.who.int/macrohealth/action/NCMH_Burden%20of%20disease_(29%20Se p%202005).pdf. Accessed on September 27, 2017.
  24. Teo WS, Tan WS, Chong WF, Abisheganaden J, Lew YJ, Lim TK, et al. Economic burden of chronic obstructive pulmonary disease. Respirology 2012;17:120–26.
  25. Ding B, Small M, Bergstrom G, Holmgren U. COPD symptom burden: impact on health care resource utilization and work and activity impairment. Int J COPD 2017;12:677–89.
  26. Van Boven JF, Vegter S, van der Molen T, Postma MJ. COPD in the working age population: the economic impact on both patients and government. COPD J 2013;10:629–39.
  27. Tachkov K, Kamusheva M, Pencheva V, Mitov K. Evaluation of the economic and social burden of chronic obstructive pulmonary disease (COPD). Biotechnol Biotec Eq 2017;31:855–61.
  28. Suhrcke M, Nugent RA, Stuckler D, Rocco L. Chronic Diseases: An Economic Perspective. London: Oxford Health Alliance; 2006.
  29. Okediji PT, Ojo AO, Ojo AI, Ojo AS, Ojo AE, Abioye- Kuteyi EA. The economic impact of chronic illness on households of patients in Ile-lfe, south-western Nigeria. Cureus 2017;9:e1756.
  30. Smith KT, Monti D, Mir N, Peters E, Tipirneni R, Politi MC. Access is necessary but not sufficient: factors influencing delay and avoidance of health care services. MDM Policy Pract 2018;3: 2381468318760298.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.